These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Adenosine deaminase activity in plasma and blood cells of patients with haematological and autoimmune diseases. Storch H; Krüger W; Rotzsch W Acta Haematol; 1981; 65(3):183-8. PubMed ID: 6785972 [TBL] [Abstract][Full Text] [Related]
7. Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism. Ambrogi F; Grassi B; Ronca-Testoni S; Ronca G Clin Exp Immunol; 1977 Apr; 28(1):80-8. PubMed ID: 405169 [TBL] [Abstract][Full Text] [Related]
8. Activity of adenosine deaminase and of purine nucleoside phosphorylase in peripheral lymphocytes from patients with acquired immunological disorders. Sidi Y; Boer P; Pick I; Pinkhas J; Sperling O Biomedicine; 1980 Apr; 33(2):39-41. PubMed ID: 6773594 [TBL] [Abstract][Full Text] [Related]
9. [Adenosine deaminase activity in blood plasma, erythrocytes and lymphocytes in leukemias]. Müller G; Krüger W; Krug K; Hempel RD; Richter V; Rose H Radiobiol Radiother (Berl); 1983; 24(3):353-5. PubMed ID: 6635165 [No Abstract] [Full Text] [Related]
10. [Adenosine deaminase, purine nucleoside phosphorylase and ecto-5'-nucleotidase--markers of acute leukemia variants]. Filanovskaia LI; Togo AV; Tsveĭbakh AS; Blinov MN; Alekseev NA Vopr Med Khim; 1987; 33(4):16-21. PubMed ID: 2821693 [TBL] [Abstract][Full Text] [Related]
11. [Decreased adenosine deaminase activity in the T-lymphocytes in Hodgkin's disease]. Müller G; Krüger W; Richter V; Krug K Z Gesamte Inn Med; 1983 Jan; 38(1):31-3. PubMed ID: 6601886 [TBL] [Abstract][Full Text] [Related]
12. [Combination assay of IAP and ADA in hematologic malignancies]. Ohata M; Masuda I; Nonaka K; Sugiura K Rinsho Byori; 1990 Jun; 38(6):703-10. PubMed ID: 2381093 [TBL] [Abstract][Full Text] [Related]
13. Cytochemical demonstration of dihydrofolate reductase in leukaemia and other haematological diseases. Tzortzatou F Scand J Haematol; 1977 Jul; 19(1):5-13. PubMed ID: 268023 [TBL] [Abstract][Full Text] [Related]
14. Enzymes of purine metabolism and membrane phenotype in malignant cells of some leukemia patients. Babusíková O; Hrivnáková A; Pechán I; Ujházy P Neoplasma; 1984; 31(6):661-6. PubMed ID: 6441124 [TBL] [Abstract][Full Text] [Related]
15. Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. Smyth JF; Poplack DG; Holiman BJ; Leventhal BG; Yarbro G J Clin Invest; 1978 Sep; 62(3):710-2. PubMed ID: 308513 [TBL] [Abstract][Full Text] [Related]
16. Adenosine deaminase activity of normal lymphocytes and leukemic cells. Ben-Bassat I; Simoni F; Holtzman F; Ramot B Isr J Med Sci; 1979 Nov; 15(11):925-7. PubMed ID: 118945 [TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase levels in blood type A patients with metastatic tumor. Formeister JF; Tritsch GL Surgery; 1976 Jan; 79(1):111-7. PubMed ID: 1246685 [TBL] [Abstract][Full Text] [Related]
18. The activity of adenosine desaminase in serum and leukocytes of leukemic patients. Błaszczyszyn M; Kłos M Adv Exp Med Biol; 1984; 165 Pt B():285-8. PubMed ID: 6586059 [No Abstract] [Full Text] [Related]
19. A biological marker model for predicting disease transitions. Klein JP; Klotz JH; Grever MR Biometrics; 1984 Dec; 40(4):927-36. PubMed ID: 6598390 [TBL] [Abstract][Full Text] [Related]